Li Yuhui is the Founding Managing Partner and Chairman of Panlin Capital. See sector focus and contact routes.
Li Yuhui is the Founding Managing Partner and Chairman of Panlin Capital, a Shanghai-based venture firm he established in 2010 after more than 10 years in top-tier Chinese investment banks like Junan Securities. His investment thesis targets early to mid-stage companies in healthcare (including biopharmaceuticals and medical devices) and B2B technology services, with a focus on sci-tech innovation in China. While specific check sizes and lead/follow behavior are not publicly detailed, Li personally leads early-stage healthcare investments and also backs growth-stage firms. Notable portfolio companies include Kangtai Bio, Hybribio, Ribo Life Science, and enterprise-service providers such as Passiontec (acquired by Meituan) and PPIO. He has also invested in growth-stage successes like Toread, Eastern Pioneer, and XGimi Technology. Li Yuhui has been named a “Forbes China Top 100 Venture Capitalist” for eight consecutive years, reflecting his sustained impact in China’s VC sector. No distinctive public writing or unique point of view beyond his stated strategy is documented in available sources.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Shanghai.
Investors like Li Yuhui · Full investor directory · Investor access · Company funding database